Clinical Trials in San Francisco

Showing 9541-9560 of 12,991 trials

A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

NCT00002377

To investigate the efficacy and safety of RS-79070 when used as induction therapy in patients with newly diagnosed peripheral retinitis. To assess the effects of induction and maintenance level dosing of RS-79070 on CMV viral load, estimated by plasma CMV PCR. To assess the pharmacokinetics of ganciclovir following administration of RS-79070 in the target population.

Cytomegalovirus RetinitisHIV Infections

Hoffmann-La RocheStarted Jan 1997

Irvine, California, United States • La Jolla, California, United States • San Diego, California, United States +16 more locations

COMPLETEDPhase 2< 1 mile

Ovarian Cancer Vaccine for Patients in Remission

NCT01068509

The purpose of this study is to determine the safety and efficacy of an investigational therapeutic agent (Cvac) in ovarian cancer patients in first or second remission and to determine its ability to prevent cancer from returning. Study objectives Primary objectives: * To confirm the safety of administering Cvac in this population. * To determine the effects of Cvac on progression-free survival (PFS). Secondary objectives: * To determine overall survival (OS) for ovarian cancer patients who receive Cvac after achieving remission in the first or second-line setting. * Evaluation of host immunologic response to Cvac administration.

Epithelial Ovarian Cancer

Prima BioMed Ltd63 participantsStarted Jul 2010

Greenbrae, California, United States • La Jolla, California, United States • Palo Alto, California, United States +15 more locations

A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

Ovarian Cancer Vaccine for Patients in Remission

Find Trials by Condition in San Francisco

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication

Comparative Outcomes Management With Electronic Data Technology (COMET) Study

Transcranial Magnetic Stimulation (TMS) for CRPS

TMS for CRPS - Pilot Study

Short Term Rescue Study of Olanzapine

Effect of Ondansetron for Withdrawal Symptoms

Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events

A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC